BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 11965535)

  • 41. Activation of p38 MAPK by damnacanthal mediates apoptosis in SKHep 1 cells through the DR5/TRAIL and TNFR1/TNF-α and p53 pathways.
    Lin FL; Hsu JL; Chou CH; Wu WJ; Chang CI; Liu HJ
    Eur J Pharmacol; 2011 Jan; 650(1):120-9. PubMed ID: 20951126
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endoplasmic reticulum stress inducers, but not imatinib, sensitize Philadelphia chromosome-positive leukemia cells to TRAIL-mediated apoptosis.
    Zhang X; Inukai T; Akahane K; Hirose K; Kuroda I; Honna H; Goi K; Kagami K; Tauchi T; Yagita H; Sugita K
    Leuk Res; 2011 Jul; 35(7):940-9. PubMed ID: 21466892
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence that the death receptor DR4 is a DNA damage-inducible, p53-regulated gene.
    Guan B; Yue P; Clayman GL; Sun SY
    J Cell Physiol; 2001 Jul; 188(1):98-105. PubMed ID: 11382926
    [TBL] [Abstract][Full Text] [Related]  

  • 44. p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha.
    Sheikh MS; Burns TF; Huang Y; Wu GS; Amundson S; Brooks KS; Fornace AJ; el-Deiry WS
    Cancer Res; 1998 Apr; 58(8):1593-8. PubMed ID: 9563466
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 5, 7-Dimethoxyflavone sensitizes TRAIL-induced apoptosis through DR5 upregulation in hepatocellular carcinoma cells.
    Yang JF; Cao JG; Tian L; Liu F
    Cancer Chemother Pharmacol; 2012 Jan; 69(1):195-206. PubMed ID: 21660448
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Capsaicin sensitizes TRAIL-induced apoptosis through Sp1-mediated DR5 up-regulation: involvement of Ca(2+) influx.
    Moon DO; Kang CH; Kang SH; Choi YH; Hyun JW; Chang WY; Kang HK; Koh YS; Maeng YH; Kim YR; Kim GY
    Toxicol Appl Pharmacol; 2012 Feb; 259(1):87-95. PubMed ID: 22200406
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity.
    Ichikawa K; Liu W; Zhao L; Wang Z; Liu D; Ohtsuka T; Zhang H; Mountz JD; Koopman WJ; Kimberly RP; Zhou T
    Nat Med; 2001 Aug; 7(8):954-60. PubMed ID: 11479629
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site.
    Takimoto R; El-Deiry WS
    Oncogene; 2000 Mar; 19(14):1735-43. PubMed ID: 10777207
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lipid raft-dependent death receptor 5 (DR5) expression and activation are critical for ursodeoxycholic acid-induced apoptosis in gastric cancer cells.
    Lim SC; Duong HQ; Choi JE; Lee TB; Kang JH; Oh SH; Han SI
    Carcinogenesis; 2011 May; 32(5):723-31. PubMed ID: 21362627
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cisplatin and a potent platinum(IV) complex-mediated enhancement of TRAIL-induced cancer cells killing is associated with modulation of upstream events in the extrinsic apoptotic pathway.
    Vondálová Blanárová O; Jelínková I; Szöor A; Skender B; Soucek K; Horváth V; Vaculová A; Andera L; Sova P; Szöllosi J; Hofmanová J; Vereb G; Kozubík A
    Carcinogenesis; 2011 Jan; 32(1):42-51. PubMed ID: 21037225
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oncogenic fusion E2A-HLF sensitizes t(17;19)-positive acute lymphoblastic leukemia to TRAIL-mediated apoptosis by upregulating the expression of death receptors.
    Zhang X; Inukai T; Hirose K; Akahane K; Kuroda I; Honna-Oshiro H; Kagami K; Goi K; Nakamura K; Kobayashi M; Endo M; Yagita H; Kurosawa H; Thomas Look A; Honda H; Inaba T; Nakazawa S; Sugita K
    Leukemia; 2012 Dec; 26(12):2483-93. PubMed ID: 22743623
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation.
    Mongkolsapaya J; Grimes JM; Chen N; Xu XN; Stuart DI; Jones EY; Screaton GR
    Nat Struct Biol; 1999 Nov; 6(11):1048-53. PubMed ID: 10542098
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diallyl trisulfide sensitizes human melanoma cells to TRAIL-induced cell death by promoting endoplasmic reticulum-mediated apoptosis.
    Murai M; Inoue T; Suzuki-Karasaki M; Ochiai T; Ra C; Nishida S; Suzuki-Karasaki Y
    Int J Oncol; 2012 Dec; 41(6):2029-37. PubMed ID: 23064375
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sulindac sulfide-induced apoptosis involves death receptor 5 and the caspase 8-dependent pathway in human colon and prostate cancer cells.
    Huang Y; He Q; Hillman MJ; Rong R; Sheikh MS
    Cancer Res; 2001 Sep; 61(18):6918-24. PubMed ID: 11559570
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The bile acid glycochenodeoxycholate induces trail-receptor 2/DR5 expression and apoptosis.
    Higuchi H; Bronk SF; Takikawa Y; Werneburg N; Takimoto R; El-Deiry W; Gores GJ
    J Biol Chem; 2001 Oct; 276(42):38610-8. PubMed ID: 11507096
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IFN-gamma induces cell death in human hepatoma cells through a TRAIL/death receptor-mediated apoptotic pathway.
    Shin EC; Ahn JM; Kim CH; Choi Y; Ahn YS; Kim H; Kim SJ; Park JH
    Int J Cancer; 2001 Jul; 93(2):262-8. PubMed ID: 11410875
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autocrine tumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1alpha-mediated NF-kappaB activation and down-regulation of TRAF2 expression.
    Hu P; Han Z; Couvillon AD; Kaufman RJ; Exton JH
    Mol Cell Biol; 2006 Apr; 26(8):3071-84. PubMed ID: 16581782
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bufotalin sensitizes death receptor-induced apoptosis via Bid- and STAT1-dependent pathways.
    Waiwut P; Inujima A; Inoue H; Saiki I; Sakurai H
    Int J Oncol; 2012 Jan; 40(1):203-8. PubMed ID: 21887462
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) up-regulates death receptor 5 (DR5) mediated by NFkappaB activation in epithelial derived cell lines.
    Shetty S; Gladden JB; Henson ES; Hu X; Villanueva J; Haney N; Gibson SB
    Apoptosis; 2002 Oct; 7(5):413-20. PubMed ID: 12207174
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects and expression of TRAIL and its apoptosis-promoting receptors in human pancreatic cancer.
    Ozawa F; Friess H; Kleeff J; Xu ZW; Zimmermann A; Sheikh MS; Büchler MW
    Cancer Lett; 2001 Feb; 163(1):71-81. PubMed ID: 11163110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.